| Not Yet Recruiting | Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma NCT07529808 | BigHat Biosciences, Inc. | Phase 1 / Phase 2 |
| Not Yet Recruiting | Eradication of Helicobacter Pylori Subtypes at High Gastric Cancer Risk: a Cluster-randomized Controlled Trial NCT06943794 | Fudan University | N/A |
| Not Yet Recruiting | A First-In-Human Phase I/IIa Study to Evaluate DA 3501 in Patients With Advanced Gastric or Gastro-esophageal NCT07481357 | Dong-A ST Co., Ltd. | Phase 1 |
| Not Yet Recruiting | Timing of Minimally Invasive Local Treatment After First-Line Systemic Therapy in Oligometastatic Esophageal o NCT07000253 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Phase 2 / Phase 3 |
| Recruiting | Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot Trial NCT07447050 | University of California, Irvine | Phase 2 |
| Recruiting | An Phase Ib/II Clinical Trial of TCC1727 Combination Therapy in Advanced Solid Tumors NCT07371663 | Beijing Tide Pharmaceutical Co., Ltd | Phase 1 / Phase 2 |
| Not Yet Recruiting | Fecal DNA Methylation and Helicobacter Pylori Gastric Cancer Susceptibility Genes Test NCT06943768 | Fudan University | — |
| Recruiting | Study of the Epidemiological, Clinical, Diagnostic, and Therapeutic Characteristics of Gastric Cancers in Alge NCT07481110 | Société Algérienne de Formation et Recherche en Oncologie | — |
| Recruiting | An Observational Study for Gastric Cancer in Carriers of High Risk Helicobacter Pylori NCT06896370 | Fudan University | — |
| Recruiting | The Safety and Clinical Efficacy of RAK Cell Therapy in Late-stage Gastric Cancer: A Randomized Controlled Tri NCT07212933 | Chinese PLA General Hospital | Phase 2 |
| Recruiting | Prospective Gastric Cancer Screening With Fecal Multi-target DNA Analysis NCT06943807 | Fudan University | — |
| Not Yet Recruiting | Investigating Multigene Methylation Dynamics in Treatment Response Surveillance for Gastric Cancer NCT06979895 | Xijing Hospital | — |
| Enrolling By Invitation | Clinical Efficacy of Pucotenlimab Combined With Lenvatinib and SOX Versus SOX Alone in Patients With HER2-Nega NCT07356466 | Fujian Medical University | EARLY_Phase 1 |
| Recruiting | A Phase Ib/II Trial of Neoadjuvant Zolbetuximab Plus Docetaxel, Oxaliplatin and S-1 Chemotherapy in Patients W NCT06732856 | Asan Medical Center | Phase 1 / Phase 2 |
| Not Yet Recruiting | Fruquintinib Combined With PD-1 Inhibitor and FOLFOX as First-Line Treatment For Advanced Gastric Cancer NCT06871527 | Sixth Affiliated Hospital, Sun Yat-sen University | Phase 1 / Phase 2 |
| Not Yet Recruiting | Development of a Predictive Model for Gastric Cancer Peritoneal Metastasis and Cachexia Using BUB1 and Radiopa NCT06858644 | Qun Zhao | — |
| Active Not Recruiting | Fecal DNA Methylation and Helicobacter Pylori SNPs Tests for Gastric Cancer NCT07312500 | Fudan University | — |
| Recruiting | XELOX Combined With Sintilimab and HBO for Advanced or Metastatic GC/GEJC NCT06742411 | West China Hospital | Phase 1 / Phase 2 |
| Not Yet Recruiting | Comparing the Efficacy of Sintilimab Plus Nab-POF Regimen, Sintilimab Plus XELOX Chemotherapy, and Lenvatinib, NCT06748508 | Fudan University | Phase 2 |
| Recruiting | Fruquintinib Combined With Trastuzumab and XELOX as First-line Treatment in Patients With HER2-positive Advanc NCT07334431 | Henan Cancer Hospital | Phase 1 / Phase 2 |
| Completed | Gastric Cancer Endoscopic Screening in an Intermediate-risk Country - ROGCAS, a Dual-centre Pilot Program NCT06316882 | Unidade Local De Saúde Do Norte Alentejano | — |
| Active Not Recruiting | A Study on the Impact of Intelligent Nutrition Management on Clinical Outcomes in Chemotherapy Patients With G NCT06997302 | Tianjin Medical University Cancer Institute and Hospital | N/A |
| Recruiting | Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes NCT04907643 | Cedars-Sinai Medical Center | N/A |
| Completed | Skeletal Muscle Mass Used to Assess Frailty in Older Gastric Cancer Patients NCT06763068 | Nanjing Medical University | — |
| Completed | Establishment of Molecular Classification Models for Early Diagnosis of Digestive System Cancers NCT05431621 | Shanghai Zhongshan Hospital | — |
| Completed | Comparison of Channel Esophagogastrostomy and Double Tract Reconstruction After Laparoscopic-assist Proximal G NCT06741124 | Northern Jiangsu People's Hospital | — |
| Active Not Recruiting | ADP-A2M4CD8 as Monotherapy or in Combination With Either Nivolumab or Pembrolizumab in HLA-A2+ Subjects With M NCT04044859 | USWM CT, LLC | Phase 1 |
| Withdrawn | Collection of Biospecimen & Clinical Information in Patients w/ Gastrointestinal Cancers NCT01031056 | Stanford University | — |
| Terminated | Advanced Gastrointestinal Endoscopic Imaging NCT01034670 | Stanford University | N/A |
| Completed | Ph II of Capecitabine, Carboplatin & Bevacizumab for Gastroesophageal Junction & Gastric Carcinoma NCT00780494 | Stanford University | Phase 2 |
| Completed | B-Receptor Signaling in Cardiomyopathy NCT01135849 | Daniel Bernstein | — |
| Terminated | Permission to Collect Blood Over Time for Research NCT00767234 | Stanford University | — |
| Recruiting | Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma NCT01048281 | Stanford University | — |
| Completed | Epidemiology and Treatment of Gastric Cancer NCT07213115 | Medizinische Hochschule Brandenburg Theodor Fontane | — |